COVID-19: CDC, FDA and CMS Guidance
This page includes AHA Today stories and other AHA content on coronavirus COVID-19 guidance from the CDC, FDA, and CMS.
The Centers for Medicare…
Statement on CMS guidance on elective procedures from AHA President and CEO Rick Pollack.
The Food and Drug Administration encouraged those who have recovered from COVID-19 to donate plasma for the creation of convalescent plasma, an antibody-rich investigational therapy that may help others fight the disease.
The Food and Drug Administration issued guidance expanding the use of telethermographic systems for triage use during the public health crisis.
The Centers for Disease Control and Prevention has collated in one location training materials for health care professionals during the COVID-19 emergency, including webinars, videos and online courses.
The Food and Drug Administration announced that spun synthetic swabs made from materials like polyester can be used for test patients for COVID-19.
The Centers for Medicare…
During the COVID-19 emergency, the Food and Drug Administration will not take action in certain circumstances against a registered outsourcing facility for compounding certain drugs to treat hospitalized patients with COVID-19; using a bulk drug substance not on the 503B bulk list; or not meeting…
The Centers for Medicare & Medicaid Services released new guidance implementing several provisions included in the Coronavirus Aid, Relief, and Economic Security Act.
The Centers for Medicare & Medicaid Services (CMS) yesterday released new guidance implementing several provisions included in the Coronavirus Aid, Relief, and Economic Security (CARES) Act. These provisions include: